Taiki Mihara1, Wataru Otsubo1, Kazuhide Horiguchi2, Shoma Mikawa1, Noriyuki Kaji1, Satoshi Iino2, Hiroshi Ozaki1, Masatoshi Hori1. 1. Department of Veterinary Pharmacology, Graduate School of Agriculture and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-8657, Japan. 2. Division of Anatomy, Department of Morphological and Physiological Sciences, University of Fukui Faculty of Medical Sciences, Fukui 910-1193, Japan.
Abstract
Regulation of inflammation in intestinal mesothelial cells in the abdominal cavity is important for the pathogeny of clinical conditions, such as postoperative ileus, peritonitis and encapsulating peritoneal sclerosis. Here we have examined the inflammatory effect of lipopolysaccharide (LPS) and the anti-inflammatory effect of nicotinic acetylcholine receptor stimulation in rat intestinal mesothelial cells. LPS upregulated mRNA expression of interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), monocyte chemotactic protein-1 (MCP-1) and inducible nitric oxide synthase (iNOS). The α7, α9 and α10 subunits of nicotinic acetylcholine receptor were detected in intestinal mesothelial cells. Nicotine (10 nM) significantly inhibited LPS-induced mRNA expression of IL-1β and iNOS, but not TNF-α and MCP-1. In addition, the α7 nicotinic acetylcholine receptor selective agonist, PNU-282987 (10 nM), significantly inhibited LPS-induced mRNA expression of IL-1β but not TNF-α, iNOS and MCP-1. Finally, we found that enteric nerves adhered to intestinal mesothelial cells located under the ileal serosa. In conclusion, intestinal mesothelial cells react to LPS to induce the production of nitric oxide from iNOS. The anti-inflammatory action of intestinal mesothelial cells expressing α7nAChR may be mediated via their connectivity with enteric nerves.
Regulation of inflammation in intestinal mesothelial cells in the abdominal cavity is important for the pathogeny of clinical conditions, such as postoperative ileus, peritonitis and encapsulating peritoneal sclerosis. Here we have examined the inflammatory effect of lipopolysaccharide (LPS) and the anti-inflammatory effect of nicotinic acetylcholine receptor stimulation in rat intestinal mesothelial cells. LPS upregulated mRNA expression of interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), monocyte chemotactic protein-1 (MCP-1) and inducible nitric oxide synthase (iNOS). The α7, α9 and α10 subunits of nicotinic acetylcholine receptor were detected in intestinal mesothelial cells. Nicotine (10 nM) significantly inhibited LPS-induced mRNA expression of IL-1β and iNOS, but not TNF-α and MCP-1. In addition, the α7 nicotinic acetylcholine receptor selective agonist, PNU-282987 (10 nM), significantly inhibited LPS-induced mRNA expression of IL-1β but not TNF-α, iNOS and MCP-1. Finally, we found that enteric nerves adhered to intestinal mesothelial cells located under the ileal serosa. In conclusion, intestinal mesothelial cells react to LPS to induce the production of nitric oxide from iNOS. The anti-inflammatory action of intestinal mesothelial cells expressing α7nAChR may be mediated via their connectivity with enteric nerves.
Mesothelial cells form a monolayer of valvate-like cells that cover organs in the body, including the abdominal, thoracic and pericardial cavities. Mesothelial cells in these organs are located on a thin basement membrane supported
by connective tissue stroma. Large quantities of microvilli and pili are seen on the cell surface, where they protect the mesothelial surface from injury by friction. Microvilli contain water and serous effusions, while pili control
the secretion of surfactant, together contributing to the physiological constancy of the serosa, which acts as the front-line barrier against bacteria, chemical substances and surgical stress. It is known that mesothelial cells
secrete acid mucopolysaccharide, proteoglycan and phospholipids, which provide a lubricated body cavity wall to prevent damage to the wall cavity from adherence [27]. Recently, however, it has
been reported that the mesothelium plays an important role in peritoneal homeostasis, such as immune surveillance, antigen presentation and wound healing [23].Mesothelial cells produce various immune-regulatory factors, such as chemokines, cytokines, growth factors, reactive oxygen species (ROS), antioxidant enzymes and extracellular matrix molecules, which can regulate the initiation and
subsequent recovery of serosal inflammation [23]. In regard to the innate immune system of the mesothelium, it has been reported that both human and mice mesothelial cells express toll-like
receptors (TLRs) 1 to 6 at the mRNA level [8]. TLR-signaling can activate nuclear factor kappa-B (NF-κB) and mitogen-activated protein kinase (MAPK) to initiate inflammation during infectious
stimuli [8]. Moreover, chemokines secreted from mesothelial cells cause the infiltration of neutrophils and monocytes, and regulate the emigration of macrophages from inflamed peritoneum.In intestinal-resident macrophages, it has been found that lipopolysaccharide (LPS) can upregulate cyclooxygenase-2 (COX-2) expression, which in turn increases inducible nitric oxide synthase (iNOS) via prostaglandin E2
(PGE2)/EP2 and/or EP4 signaling [13, 21, 29]. Induced PGE2 and nitric oxide (NO) directly act
upon intestinal smooth muscle cells to induce gastrointestinal motility disorders, such as postoperative ileus and peritonitis [14, 21, 28]. In addition, it is thought that peritoneal macrophages may also play an important role in the pathogeny of postoperative ileus [19]. All gut organs are
covered with mesothelial cells of the abdominal cavity, suggesting the possibility that intestinal mesothelial cells (IMCs) may be involved in the supply of NO in both conditions, given that they may react to LPS to produce COX-2 and
iNOS.In recent years, accumulating evidence has shown that vagus nerve stimulation has anti-inflammatory effects via activation of macrophage α7 nicotinic acetylcholine receptors (α7nAChRs) in the spleen, named as a vagovagal cholinergic
anti-inflammatory reflex [26, 30]. Furthermore, in the small intestine, a similar anti-inflammatory pathway regulated by α7nAChR exists in the myenteric
plexus neural network [20, 32], and muscularis-resident macrophages expressing α7nAChR are candidates for the induction of this anti-inflammatory action
[3, 20]. The peripheral vagus nerve preferentially interacts with the myenteric neural network, with nerve endings in close proximity to muscularis
resident macrophages [3]. However, it is still unclear whether IMCs similarly react with the peripheral autonomic neuronal network. On the other hand, it has been reported that cell growth of
human mesothelial cells is regulated through the expression of α7nAChR [31], lending support to the idea that IMCs, in addition to muscularis resident macrophages, can negatively regulate
inflammation through an α7nAChR signaling pathway.Peritoneal dialysis is one of the approaches for the treatment of kidney failure. Although this treatment is better than hemodialysis, because of odd-hour therapy and reduced cardiovascular invasiveness, long-term peritoneal dialysis
causes encapsulating peritoneal sclerosis [37]. This is because mesothelial cells are repeatedly exposed to high glucose and low pH, resulting in a high osmotic pressure that promotes the
secretion of various inflammatory mediators and induces peritoneal inflammation. Effective suppression of peritonitis in the clinic could reduce encapsulating peritoneal sclerosis and the risks associated with long-term peritoneal
dialysis.With this in mind, we examined the inflammatory effect of LPS and the anti-inflammatory effect of α7nAChR stimulation in rat IMCs. We found that IMCs react to LPS, in turn inducing the iNOS gene to produce NO. In
addition, IMCs were found to express α7nAChR and produce an anti-inflammatory action that could potentially be mediated through the attachment of these cells to enteric nerves.
MATERIALS AND METHODS
Animals
Seven- to twelve-week-old male Sprague-Dawley rats were used in this study. Rats were housed under controlled conditions (25°C, 12 hr light-dark cycles). All animal experiments were performed according to the Guide for Animal Use
and Care published by the University of Tokyo and were approved by the Institutional Review Board of The University of Tokyo (approval code P10-482).
Isolation and culture of IMCs
The IMCs were isolated according to recent reports [9, 18]. Briefly, the intestines of rats were isolated, washed with Hank’s balanced salt solution
(HBSS) and incubated in 0.25% trypsin in HBSS for 30 min. The fluids were then centrifuged at 200 g for 5 min at 4°C before aspirating the supernatant and re-suspending the pellets in Dulbecco’s modified Eagle’s medium (DMEM)
containing 10% fetal bovine serum (FBS). The isolated IMCs were incubated in 60 mm dishes at 37°C in a 95% O2 / 5% CO2 incubator until 60–80% confluent. The culture solution was changed the day following
isolation and every 3–4 days thereafter. For experiments, primary culture cells (P-0) were used. Cells were cultured with 10% FBS in the incubator. Serum starvation was performed 24 hr before the experiments.
Immunostaining
IMCs cultured on cover glasses were fixed in 5% neutral buffered formalin at 37°C for 5 min. After fixation, the cells were washed three times in Tris-buffered saline (TBS) for 30 min each, then with 0.1% Triton-X100 in TBS
containing 1% bovine serum albumin (BSA) for 90 sec. After membrane permeabilization, the cells were incubated with 1% BSA in TBS at room temperature for 30 min to reduce non-specific binding. Subsequently, the cells were
incubated with 1:100 diluted mousevimentin antibody (Nichirei Co., Tokyo, Japan, H912) in TBS with 2% BSA at room temperature for 1 hr. After washing with TBS for 30 min at 4°C, the cells were incubated with 1:250 diluted Alexa
Fluor® 488 goat anti-mouse IgG secondary antibody and 1:50 diluted Rhodamine-Phalloidin (Molecular Probes, Eugene, OR, U.S.A., R-415), which is an F-actin probe conjucted to red fluorescent dye and stabilizes actin filaments, in
TBS at room temperature for 1 hr. After washing twice with TBS, the cells were incubated with DAPI (1 µg/ml) for 5 min. The cells were washed twice and mounted on glass slides. We used an Eclipse
E800 (Nikon) for observation.
Semi-quantitative RT-PCR
Total RNA was extracted from IMCs using TRIzol reagent (Molecular Research Center, Inc., Cincinnati, OH, U.S.A.) according to the manufacturer’s instructions. Total RNA was reverse transcribed using ReverTra Ace in conjunction
with random 9-mer oligonucleotide primers (Takara Bio, Otsu, Japan) at 30°C for 10 min, 42°C for 1 hr and 99°C for 5 min. RT-PCR was performed using Taq DNA polymerase (Takara Bio) and a Thermal Cycler TP600 (Takara Bio). The cDNA
was amplified for 32 cycles, consisting of 98°C for 10 sec, 55–58°C for 30 sec and 72°C for 1 min. Expression values were normalized to GAPDH mRNA levels and expressed relative to the control sample. PCR products
were resolved on 2% agarose gels containing 0.015 µl/ml ethidium bromide. Bands were visualized with a UV transilluminator (TOYOBO, Osaka, Japan), and their density was measured using NIH image
software (Image J, ver 1.51). Primer sets and the expected sizes for RT-PCR are shown in Table 1.
Table 1.
Primer sets and expected product sizes for semi-quantitative RT-PCR
Target gene
Primer sequences
Product sizes (bp)
Forward
Reverse
GAPDH
TCCCTCAAGATTGTCAGCAA
AGATCCACAACGGATACATT
308
Mesothelin
TAGCCCCTGARGACATCCRSCAGTGG
CAACCGCCACATRACACTG
251
Keratin 5
AAGGCCCAGTACGAGGACATT
GGTGTTCATGAGCTCCTGGTA
351
COX-2
CTGTATCCCGCCCTCGTGGTG
ACTTGCGTTGATGGTGGCTGTCTT
282
iNOS
AAGRGAGTGYTGTTCCAGGT
CCACCAGCTTCTTCAAMGTG
184
IL-1β
TCCATGAGCTTTGTACAAGG
GGTGCTGATGACCAGTTGG
246
TNF-α
AAATGGGCTCCCTCTCATCA
AGCCTTGTCCCTTGAAGAGA
248
MCP-1
CAACTCTCACTGAAGCCAGA
AAATGGATCTACATCTTGCA
600
α7nAChR
ATGGTGGCAAATGCCTAAG
CTCGGAAGCCAATGTAGAGC
204
α9nAChR
TCCTGGACCTACAATGGAAA
CTCCCAGAGAGACCTTCTCC
295
α10nAChR
AGATTGGAAGCGTCTGGCTA
TGCTCATCTGGCATTGAGTCTTA
391
Electron microscopy
Intestines were placed in a fixative containing 3% glutaraldehyde and 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, for 2 hr at room temperature. Tissues were then post-fixed in 1% osmium tetroxide for 2 hr at 4°C,
rinsed in distilled water, block-stained with saturated aqueous uranyl acetate solution for 3 hr, dehydrated in a graded series of ethyl alcohol and embedded in Epon 812. Ultrathin sections were cut with a Leica ultramicrotome,
stained with uranyl acetate and lead citrate, and examined using a Hitachi H-7650 electron microscope (Hitachi, Tokyo, Japan).
Data analysis
Results are expressed as mean ± SEM. Data were evaluated using Student’s t-test for two groups and one-way ANOVA followed by Tukey’s test for comparisons between more than three groups. P values
˂0.05 were considered statistically significant.
RESULTS
Figure 1A shows typical results of immunohistochemistry of cultured rat primary IMCs. IMCs grew with a pavement-like form and a mesh-like vimentin filamentous network inside the cytoplasm. Actin fiber networks formed peripherally to
the cells. Total RNA was extracted from cultured rat IMCs, the IEC-6 rat epithelial cell line and rat intestinal mucosa, with RT-PCR performed for keratin 5 and mesothelin, marker proteins for IMCs. Keratin 5 was detected in primary
cultured IMCs but not the IEC-6 cell line, while mesothelin was expressed in IMCs and IEC6 but not in intestinal mucosa (Fig. 1B).
Fig. 1.
Characterization of rat primary cultured IMCs. (A) Typical immunohistochemistry images of cultured rat IMCs. Red, green or blue signals indicate actin, vimentin or the cell nucleus, respectively. Scale bar represents 50
µm. (B) The mRNA expression of mesothelin and keratin 5 in rat mesothelial cells (MES). Intestinal mucosa (MUC) and the intestinal epithelial cell line, IEC6, were used for comparison. Product sizes were 308
bp for GAPDH, 351 bp for keratin 5 and 251 bp for mesothelin.
Characterization of rat primary cultured IMCs. (A) Typical immunohistochemistry images of cultured rat IMCs. Red, green or blue signals indicate actin, vimentin or the cell nucleus, respectively. Scale bar represents 50
µm. (B) The mRNA expression of mesothelin and keratin 5 in rat mesothelial cells (MES). Intestinal mucosa (MUC) and the intestinal epithelial cell line, IEC6, were used for comparison. Product sizes were 308
bp for GAPDH, 351 bp for keratin 5 and 251 bp for mesothelin.We next investigated time- and concentration-dependent changes in COX-2 and iNOS expression mediated by LPS (Fig. 2A and 2B). Results indicated that COX-2 and iNOS gene induction reached a maximum 2 and 4 hr after stimulation with LPS, respectively. COX-2 expression was down-regulated close to
resting levels within 24 hr following LPS stimulation. In contrast, iNOS expression was maintained for more than 24 hr after stimulation. We also investigated the effect of LPS concentration on iNOS
induction over a 4 hr stimulation period. Results indicated that 100 ng/ml LPS induced the maximum level of induction (Fig. 2C). We subsequently
investigated the effect of LPS (100 ng/ml, 4 hr stimulation) on interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α) and monocyte chemotactic protein-1
(MCP-1) expression (Fig. 2D–F), with results showing that expression of all three genes was significantly increased by LPS stimulation.
Fig. 2.
Effect of LPS on the mRNA expression of inflammatory mediators in rat IMCs. Time-dependent changes in COX-2 (A) or iNOS (B) mRNA expression mediated by LPS (1 µg/ml, n=4–6 each). (C)
Concentration-dependent change in iNOS expression mediated by LPS (10–10,000 ng/ml, n=4−6 each). Data are mean ± SEM; *P<0.05 and **P<0.01 vs. resting
values. (D–F) Upregulation of inflammatory mediators (IL-1β, TNF-α and MCP-1) by LPS (100 ng/ml) after 4 hr. Each column shows mean ± SEM
(n=4–6); *P<0.05 and **P<0.01 vs. resting or before stimulation with LPS.
Effect of LPS on the mRNA expression of inflammatory mediators in rat IMCs. Time-dependent changes in COX-2 (A) or iNOS (B) mRNA expression mediated by LPS (1 µg/ml, n=4–6 each). (C)
Concentration-dependent change in iNOS expression mediated by LPS (10–10,000 ng/ml, n=4−6 each). Data are mean ± SEM; *P<0.05 and **P<0.01 vs. resting
values. (D–F) Upregulation of inflammatory mediators (IL-1β, TNF-α and MCP-1) by LPS (100 ng/ml) after 4 hr. Each column shows mean ± SEM
(n=4–6); *P<0.05 and **P<0.01 vs. resting or before stimulation with LPS.Because normal human mesothelial cells express α7nAChR [4, 31], we examined the subtypes of nAChRs expressed in rat IMCs, rat ileal smooth muscle and rat
brain. Expression of nAChR subunits, α7, α9 and α10, were all detected in rat IMCs, as well as in ileal smooth muscle and brain (Fig. 3).
Fig. 3.
mRNA expression of α7, α9 and α10 subunits of nAChRs in IMCs, ileal muscle layer and brain cortex in rat. The expression of α7, α9 and α10 nAChR subunits was measured in rat IMCs, with rat ileal muscle and brain cortex used
for comparison or as a positive control, respectively. The product sizes were 308 bp for GAPDH, 204 bp for α7nAChR, 295 bp for α9nAChR and 391 bp for α10nAChR.
mRNA expression of α7, α9 and α10 subunits of nAChRs in IMCs, ileal muscle layer and brain cortex in rat. The expression of α7, α9 and α10 nAChR subunits was measured in rat IMCs, with rat ileal muscle and brain cortex used
for comparison or as a positive control, respectively. The product sizes were 308 bp for GAPDH, 204 bp for α7nAChR, 295 bp for α9nAChR and 391 bp for α10nAChR.Subsequently, we compared the effect of nicotine (10 nM) on the LPS-induced mRNA expression of the inflammatory mediators, IL-1β, TNF-α, iNOS and MCP-1. Results
indicated that nicotine significantly inhibited IL-1β and iNOS gene expression, but not TNF-α and MCP-1 (Fig. 4). We next examined the effect of PNU-282987 (PNU), one of α7nAChR selective agonist, on the LPS-induced mRNA expression of the inflammatory mediators, IL-1β, TNF-α, iNOS and
MCP-1. Results showed that PNU significantly inhibited IL-1β gene expression, but not TNF-α, iNOS and MCP-1 (Fig. 4).
However, in case of TNF-α, we considered that nicotine and PNU tended to inhibit the mRNA expression.
Fig. 4.
Anti-inflammatory effect of PNU-282987 and nicotine on LPS-induced mRNA expression of inflammatory mediators in IMCs. Rat mesothelial cells were treated with PNU-282987 (10 nM) and nicotine (10 nM) in the presence or absence
of LPS (100 ng/ml) for 4 hr. PNU-282987 and nicotine were added 30 min before LPS application. (A–D) show results from IL-1β, TNF-α, iNOS and MCP-1, respectively. Each column shows mean ± SEM
from four independent experiments (n=4−15); *P<0.05, **P<0.01 and ***P<0.001 vs. control values, and #P<0.05 and
##P<0.01 vs. LPS values.
Anti-inflammatory effect of PNU-282987 and nicotine on LPS-induced mRNA expression of inflammatory mediators in IMCs. Rat mesothelial cells were treated with PNU-282987 (10 nM) and nicotine (10 nM) in the presence or absence
of LPS (100 ng/ml) for 4 hr. PNU-282987 and nicotine were added 30 min before LPS application. (A–D) show results from IL-1β, TNF-α, iNOS and MCP-1, respectively. Each column shows mean ± SEM
from four independent experiments (n=4−15); *P<0.05, **P<0.01 and ***P<0.001 vs. control values, and #P<0.05 and
##P<0.01 vs. LPS values.Finally, we performed electron microscopic analysis for evidence that an enteric neural network exists within the serosa of the small intestine. In this analysis, IMCs were found to be attached to fibroblast-like cells and
subserosal resident macrophages (Fig. 5A). In addition, the results indicated the existence of an enteric neural network peripheral to the intestinal serosa that demonstrated connectivity with IMCs (Fig. 5B).
Fig. 5.
Electron microscopic images of ileal serosa. (A) IMCs attached with fibroblast-like cells and resident macrophages. (B) Peripheral enteric neural network which adhered to IMCs distributed in the intestinal serosa. SM, smooth
muscle cell; F, fibroblast like cell; M, macrophage; arrows, mesothelial cells.
Electron microscopic images of ileal serosa. (A) IMCs attached with fibroblast-like cells and resident macrophages. (B) Peripheral enteric neural network which adhered to IMCs distributed in the intestinal serosa. SM, smooth
muscle cell; F, fibroblast like cell; M, macrophage; arrows, mesothelial cells.
DISCUSSION
Mesothelin is a differentiation antigen that can be considered a good marker protein for IMCs, since its expression is confined to mesothelial cells derived from the pleural cavity, pericardium and peritoneum [5, 6]. In the present study, the primary cells that we isolated were shown to express mesothelin, supporting the concept that they represented IMCs. Further testing indicated
that intact intestinal mucosa did not express mesothelin as expected; however, the cultured IEC-6 rat epithelial cell line did express mesothelin. There are reports that mesothelin is overexpressed in some cancer cells, such as
pancreatic adenocarcinoma, ovarian cancer, pulmonary adenocarcinoma and mesothelioma [1, 12, 24, 25], which may explain the expression of mesothelin in the IEC-6 line, an immortalized cell strain. Further evidence that the primary cultured cells were IMCs was provided by the fact that they
were positive for vimentin (typical of mesenchymal stromal cells) and also keratin 5 (another marker of the mesothelium).TLRs (types 1 to 6) are known to be expressed in mesothelial cells and to participate in innate immune responses [8]. In macrophages, it is well known that LPS, the film component of the
gram-negative bacillus, activates TLR4, which in turn induces expression of iNOS, COX-2 and inflammatory cytokines [17]. In the present study, rat IMCs
stimulated with LPS induced the expression of the inflammatory mediators, COX-2, iNOS, IL-1β, TNF-α and MCP-1, supporting the notion that
IMC-associated inflammatory immunoresponses following LPS stimulation depend on TLR4 activation, as previously reported [8].In recent years, a vagus nerve-mediated cholinergic anti-inflammatory reflex in the spleen was identified, in addition to a neural anti-inflammatory mechanism regulated by glucocorticoid production and the
hypothalamic–pituitary–adrenal (HPA) axis [11, 30]. In the gastrointestinal tract, another local anti-inflammatory pathway that does not require the
involvement of the spleen has been demonstrated [3, 20, 32]. The target cells of the cholinergic anti-inflammatory
reflex are macrophages expressing α7nAChR [10, 34, 35], a monomeric nAChR formed by α7 subunit pentamers [7]. α7nAChR is mainly expressed in central neural cells, but is also expressed in immunoreactive cells, such as macrophages [7]. Recent work has revealed that
normal human mesothelial cells, and also humanmesothelioma cell lines, express functional α7nAChRs [4, 30], indicating the possibility that α7nAChRs may
also be expressed in rat IMCs. In this study, nicotine inhibited the mRNA expression of the inflammatory mediators, iNOS, IL-1β and TNF-α, suggesting that nAChRs may indeed be involved in the
anti-inflammatory actions of IMCs.We further examined the effect of nicotine and a selective α7nAChR agonist, PNU, in this experimental system. Not only PNU but also nicotine inhibited mRNA expression of IL-1β and tended to inhibit
TNF-α in rat IMCs. However, PNU did not reduce mRNA expression iNOS, while nicotine significantly inhibited. These findings suggest that not only α7nAChR but also other types of nAChR participate in the
anti-inflammatory action of nicotine in rat IMCs. In fact, in the current study, three types of nAChR subunits, α7, α9 and α10, were detected in IMCs. It has been reported that the α9 and α10 subunits might participate in the
anti-inflammatory action mediated by nicotine, suggesting the existence of complexed nAChRs formed by α7/α9/α10 subunits [22]. Similarly, an anti-inflammatory role has been described for
complex nAChR of the α4/β2 subtype in the gastrointestinal tract [33]. On the other hand, it is also possible to be considered that PNU tended to inhibit the LPS-induced iNOS
induction as similar with the case of nicotine treatment. From the viewpoint of this idea, PNU and nicotine may activate the same nAChR, possibly α7nAChR, because PNU and nicotine caused similar reaction against the LPS-induced
cytokines expression. Recent reports showed that JAK2-STAT3 pathway might function as pivotal bridge between α7nAChRs and NF-κB regulation [2]. Moreover, IκB, which was recognized as a key
regulator of NF-κB, prevented the NF-κB activation in resting state [2], suggesting this regulation might happen in IMC. Further studies are required to increase our understanding around this
point.The morphological finding of an association of the autonomic nervous system with the gastrointestinal serosa is unprecedented. In this study, we have shown for the first time clear morphological evidence for such an association by
electron microscopy. It remains uncertain whether the nerve fascicle distributed under the serosa in fact represents the efferent vagus nerve, but the data suggest the possibility of an anti-inflammatory response capacity via
peripheral cholinergic innervation to the serosa. Alternatively, since the acetylcholine-synthesizing enzyme choline acetyltransferase has been reported in a wide range of cell types, including endothelial, epithelial, muscle,
immune and mesothelial cells, it may be that mechanisms involving non-neuronal acetylcholine are available to react with intestinal target cells, such as IMCs [15, 16, 36].In summary, we have found that IMCs have an immunoresponse capability in response to LPS-stimulation that results in the induction of inflammatory mediators, such as COX-2, iNOS,
IL-1β, TNF-α and MCP-1. In addition, we have provided evidence that α7AChRs, and potentially other type of nAChRs, play an anti-inflammatory role in IMCs, which may in turn be
regulated by peripheral autonomic innervation under the serosa. As such, IMCs represent an important target for therapeutic strategies to reduce the risk of postoperative ileus, peritonitis and encapsulating peritoneal
sclerosis.
Authors: Wouter J de Jonge; Esmerij P van der Zanden; Frans O The; Maarten F Bijlsma; David J van Westerloo; Roelof J Bennink; Hans-Rudolf Berthoud; Satoshi Uematsu; Shizuo Akira; Rene M van den Wijngaard; Guy E Boeckxstaens Journal: Nat Immunol Date: 2005-07-17 Impact factor: 25.606
Authors: Sven Wehner; Florian F Behrendt; Boris N Lyutenski; Mariola Lysson; Anthony J Bauer; Andreas Hirner; Jörg C Kalff Journal: Gut Date: 2006-06-29 Impact factor: 23.059
Authors: Yazmin Debray-García; Elsa I Sánchez; Rafael Rodríguez-Muñoz; Miguel A Venegas; Josue Velazquez; José L Reyes Journal: Life Sci Date: 2016-08-02 Impact factor: 5.037
Authors: Esmerij P van der Zanden; Susanne A Snoek; Sigrid E Heinsbroek; Oana I Stanisor; Caroline Verseijden; Guy E Boeckxstaens; Maikel P Peppelenbosch; David R Greaves; Siamon Gordon; Wouter J De Jonge Journal: Gastroenterology Date: 2009-05-07 Impact factor: 22.682
Authors: Chantal S Colmont; Anne-Catherine Raby; Vincent Dioszeghy; Emmanuel Lebouder; Thomas L Foster; Simon A Jones; Mario O Labéta; Ceri A Fielding; Nicholas Topley Journal: Nephrol Dial Transplant Date: 2011-06-01 Impact factor: 5.992
Authors: Sarah C Ray; Babak Baban; Matthew A Tucker; Alec J Seaton; Kyu Chul Chang; Elinor C Mannon; Jingping Sun; Bansari Patel; Katie Wilson; Jacqueline B Musall; Hiram Ocasio; Debra Irsik; Jessica A Filosa; Jennifer C Sullivan; Brendan Marshall; Ryan A Harris; Paul M O'Connor Journal: J Immunol Date: 2018-04-16 Impact factor: 5.422
Authors: Elvio Mazzotta; Egina Criseida Villalobos-Hernandez; Juan Fiorda-Diaz; Alan Harzman; Fievos L Christofi Journal: Front Pharmacol Date: 2020-11-24 Impact factor: 5.810